1 interaction related to quinolone
Ciprofloxacin is a potent inhibitor of CYP1A2, the enzyme that metabolizes caffeine. Co-administration can reduce caffeine clearance by 30% to 50% and prolong its half-life, leading to higher plasma caffeine levels, jitteriness, insomnia, palpitations, tremor, and (rarely) seizures.